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Evolving Concepts in the
Management of Left Main
Coronary Disease*Marie-Claude Morice, MD
Massy, France
Once again, this productive team of renowned investigators,
Tiroch et al. (1), has made a substantial contribution to the
advancement of medical knowledge by carrying out a thor-
oughly designed and rigorously conducted study with an
exhaustive follow-up of its patients. The study was per-
formed in 607 patients with unprotected left main disease
treated with either a Cypher (Cordis Corp., Johnson &
Johnson, Miami Lakes, Florida) or a Taxus (Boston
Scientiﬁc, Natick, Massachusetts) stent; both stents having
been shown to be associated with equivalent outcomes in
a previous publication by the same investigators (2).See page 29In this issue of JACC: Cardiovascular Interventions, Tiroch
et al. (1) chose to focus on the outcome of patients under-
going percutaneous coronary intervention (PCI) for unpro-
tected left main coronary disease according to the technical
strategy implemented.
Indeed, previous trials such as SYNTAX (Synergy Be-
tween Percutaneous Intervention With Taxus and Cardiac
Surgery) (3,4) and several meta-analyses have been instru-
mental in lifting the long-standing taboo on alternative
treatments to mandatory surgery for left main coronary
artery disease by demonstrating that PCI is as effective as
surgery in the treatment of left main disease as opposed to
3-vessel coronary artery disease for which surgery, compared
with PCI, is still associated with signiﬁcantly better
outcomes. I agree with the investigators’ very relevant
remark that, despite these results, the proportion of patients
treated by PCI, as an alternative option to coronary artery
bypass graft, is still higher for those presenting with 3-vessel*Editorials published in JACC: Cardiovascular Interventions reﬂect the views of
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Interventions or the American College of Cardiology.
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disease.
However, although PCI for left main disease is increas-
ingly recognized as a safe and effective treatment, there are
still many uncertainties as to which technical strategy is
likely to provide the best results.
Tiroch et al. (1) have undertaken to address unresolved
issues regarding the optimal techniques to be applied by
carrying out a thorough angiographic follow-up analysis of
the entire patient cohort. As underlined by the investigators,
the well-documented disadvantage of such a high rate of
angiographic follow-up is that it generated a higher rate of
repeat intervention, for instance, than did the SYNTAX
trial, whereas the other results were equivalent. Nevertheless,
the investigators were able to analyze the occurrence of
restenosis according to the technique used.What Are the Investigators’ Findings?
To be able to carry out PCI in unprotected left main disease
successfully, one must learn how to treat the distal left main,
as it is the most frequently diseased segment.
Furthermore, they conﬁrm a previously reported fact,
namely that the presence of a true bifurcation lesion of
the left main coronary artery (Medina 1,1,1) is in itself
a predictor of adverse events.
Another important point is that the implantation of a single
stent in the distal left main segment provides better results
than does dual stenting; this conﬁrms and is consistent with
the results of several studies on coronary bifurcations (5).
With respect to dual stent implantation in the upper left
main coronary artery, the culotte and T-stenting techniques
are associated with similar results.
Tiroch et al. (1) also underline the fact that whereas ﬁnal
kissing balloon inﬂation does not improve the result, it does
not alter it negatively either. In short, the few additional
minutes spent performing kissing inﬂation are not com-
pletely wasted as they may prove useful should future
interventions in the stented vessel become necessary.
As in all studies, there are certain limitations that should be
mentioned. No additional information was collected re-
garding the other stenting techniques used in the setting of
coronary bifurcation PCI. These techniques include the crush
strategy, which is currently being progressively discarded due
to its suboptimal mid- and long-term results. There are no
data on the performance of dedicated stents that were not
used in the study. Finally, this study does not provide any
insight into the outcome of the newer generation stents such
as Xience (Abbott Vascular, Santa Clara, California), or
Biomatrix (Biosensors International, Singapore, Republic of
Singapore) and Nobori (Terumo, Somerset, New Jersey),
which have shown their superiority in reducing the rate of
adverse events in high-risk patients undergoing PCI, as well
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38as the occurrence of stent thrombosis compared with the ﬁrst-
generation devices used in the study reported here.
In theory, these new stents are considered able to push the
boundaries beyond the current limit of a Syntax score >32,
as it is becoming increasingly obvious that the Syntax score is
stent-dependent (6). This issue will unfortunately not
be addressed in the EXCEL (Evaluation of XIENCE
PRIME Everolimus Eluting Stent System (EECSS) or
XIENCE V EECSS or XIENCE Xpedition EECSS or
XIENCE PRO EECSS Versus Coronary Artery Bypass
Surgery for Effectiveness of Left Main Revascularization)
study in which patient enrollment is limited by a Syntax
score of 32.
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